Shares of Align Tech ALGN decreased 0.1% in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased 968.57% over the past year to $3.04, which beat the estimate of $2.55.
Revenue of $1,011,000,000 higher by 186.96% year over year, which beat the estimate of $937,880,000.
Guidance
Align Tech hasn't issued any earnings guidance for the time being.
The upcoming fiscal year's revenue expected to be between $3,850,000,000 and $3,950,000,000.
Conference Call Details
Date: Jul 28, 2021
Time: 04:30 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/s2cek48u
Price Action
Company's 52-week high was at $653.86
52-week low: $279.83
Price action over last quarter: Up 3.42%
Company Description
Align Technology is a medical (dental) device company primarily known for the Invisalign system, which is an alternative to traditional braces to correct a wide range of malocclusions. The company also manufactures intraoral scanners and computer-aided design/computer-aided manufacture digital services to support the customization of these liners. Historically, only orthodontists serviced this product, but more recently the company has expanded its direct marketing efforts to include generalists (dentists) and consumers.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.